Drug Trial Radar · NCT07818915
A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants
Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
112
Planned (sponsor's estimate)
Start
Sep 15, 2026
Primary completion
Dec 26, 2028
Study completion Dec 26, 2028
Sponsor
- Lead sponsor
- ViiV HealthcareGSK (GSK)
- Sponsor type
- Industry
- First posted
- Sep 14, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study evaluates the PK, safety, and tolerability of a single increasing dose of VH4367310, a cabotegravir (CAB) prodrug, when administered intramuscularly in healthy adult participants 18 to 55 years of age.
Conditions
- HIV Infections
Interventions
VH4367310Drug
VH4367310 will be administered intramuscularly.
PlaceboDrug
Placebo will be administered intramuscularly.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under the concentration time curve from time zero to last quantifiable time point (AUC0-tlast) of VH4367310 and CABTime frame: Up to Week 72
- Maximum observed plasma concentration (Cmax) of VH4367310 and CABTime frame: Up to Week 72
- Time to maximum observed plasma concentration (Tmax) of VH4367310 and CABTime frame: Up to Week 72
- Number of participants with drug-related adverse events (AEs)Time frame: Up to Week 72
- Number of participants with AEs as per severityTime frame: Up to Week 72
- Number of participants with drug-related serious adverse events (SAEs)Time frame: Up to Week 72
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
GSK Investigational Site
Glendale, California · Recruiting
GSK Investigational Site
Baltimore, Maryland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.